Top

Published in:

Open Access 01-12-2022 | COVID-19 | Letter

Choosing the right reference cohort for assessing outcome of venovenous ECMO

Authors: Alexander Supady, Paul M. Biever, Dawid L. Staudacher, Tobias Wengenmayer

Published in: Critical Care | Issue 1/2022

Excerpt

We thank Karagiannidis et al. for reporting important mortality data of COVID-19 patients supported with extracorporeal membrane oxygenation (ECMO) in Germany [1]. The mortality they reported was notably higher than in other large cohorts [2]. The data come from nationwide billing data of all hospitals in Germany; therefore, the risk of selection bias or underreporting of negative results is lower than in previous cohorts. …

Karagiannidis C, Slutsky AS, Bein T, Windisch W, Weber-Carstens S, Brodie D. Complete countrywide mortality in COVID patients receiving ECMO in Germany throughout the first three waves of the pandemic. Crit Care. 2021;25(1):413.CrossRef

Barbaro RP, MacLaren G, Boonstra PS, Combes A, Agerstrand C, Annich G, Diaz R, Fan E, Hryniewicz K, Lorusso R, et al. Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry. Lancet. 2021;398(10307):1230–8.CrossRef

Supady A, Badulak J, Evans L, Curtis JR, Brodie D. Should we ration extracorporeal membrane oxygenation during the COVID-19 pandemic? Lancet Respir Med. 2021;9(4):326–8.CrossRef

Supady A, Taccone FS, Lepper PM, Ziegeler S, Staudacher DL. Group CO-S: survival after extracorporeal membrane oxygenation in severe COVID-19 ARDS: results from an international multicenter registry. Crit Care. 2021;25(1):90.CrossRef

Abrams D, Ferguson ND, Brochard L, Fan E, Mercat A, Combes A, Pellegrino V, Schmidt M, Slutsky AS, Brodie D. ECMO for ARDS: from salvage to standard of care? Lancet Respir Med. 2019;7(2):108–10.CrossRef

MacLaren G, Fisher D, Brodie D. Treating the Most Critically Ill Patients With COVID-19: The Evolving Role of Extracorporeal Membrane Oxygenation. JAMA. 2022;327(1):31–2. https://doi.org/10.1001/jama.2021.22580.CrossRefPubMed

Beauchamp T, Childress J. Principles of biomedical ethics. Oxford: Oxford Press; 2001.

Bercker S, Petroff D, Polze N, Karagianidis C, Bein T, Laudi S, Stehr SN, Voelker MT. ECMO use in Germany: an analysis of 29,929 ECMO runs. PLoS ONE. 2021;16(12):e0260324.CrossRef

Title: Choosing the right reference cohort for assessing outcome of venovenous ECMO
Authors: Alexander Supady
Paul M. Biever
Dawid L. Staudacher
Tobias Wengenmayer
Publication date: 01-12-2022
Publisher: BioMed Central
Keywords: COVID-19
ECMO
ECMO
Published in: Critical Care / Issue 1/2022
Electronic ISSN: 1364-8535
DOI: https://doi.org/10.1186/s13054-021-03880-3

At a glance: The STEP trials

Springer Medicine

Choosing the right reference cohort for assessing outcome of venovenous ECMO

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Impact of prolonged requirement for insulin on 90-day mortality in critically ill patients without previous diabetic treatments: a post hoc analysis of the CONTROLING randomized control trial

Timing of inspiratory muscle activity detected from airway pressure and flow during pressure support ventilation: the waveform method

Breath-by-breath P0.1 measured on quasi-occlusion via Hamilton C6 may result in underestimation of respiratory drive and inspiratory effort

Identifying clinical subtypes in sepsis-survivors with different one-year outcomes: a secondary latent class analysis of the FROG-ICU cohort

Omega-6 sparing effects of parenteral lipid emulsions—an updated systematic review and meta-analysis on clinical outcomes in critically ill patients

An updated HACOR score for predicting the failure of noninvasive ventilation: a multicenter prospective observational study